Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease
Jason M. Norman(Vedantra Pharmaceuticals (United States)), Herbert W. Virgin(Southwestern Medical Center), Dermot McGovern(Salford Royal NHS Foundation Trust), Catherine Y. Liu(Fleet Science Center), Guoyan Zhao(Washington University in St. Louis), Amal Kambal(Washington University in St. Louis), Thaddeus S. Stappenbeck(Cleveland Clinic), Ramnik J. Xavier(Massachusetts General Hospital), Lindsay Droit(Washington University in St. Louis), Phillip Fleshner(Cedars-Sinai Medical Center), Brian C. Keller(Washington University in St. Louis), Miles Parkes(Cambridge University Hospitals NHS Foundation Trust), Megan T. Baldridge(Washington University in St. Louis), Dirk Gevers(Janssen (Belgium)), Cynthia L. Monaco(Washington University in St. Louis), Jenny Sauk(Harvard University), David Wang(Washington University in St. Louis), Ali Keshavarzian(Utrecht University), Ece Mutlu(University of Illinois Chicago), Scott A. Handley(Washington University in St. Louis)
Cited by 1,316
Related Papers
Metagenomic biomarker discovery and explanation
|Genome biology|2011|16.7k
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing
|Nature Methods|2012|4.5k
Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons
|Genome Research|2011|3.6k